Eriksson K - Search Results

1

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.

Holmgren J, Adamsson J, Anjuère F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S. Holmgren J, et al. Among authors: eriksson k. Immunol Lett. 2005 Mar 15;97(2):181-8. doi: 10.1016/j.imlet.2004.11.009. Epub 2004 Dec 7. Immunol Lett. 2005. PMID: 15752556 Review.

2

Recent advances in mucosal vaccines and adjuvants.

Eriksson K, Holmgren J. Eriksson K, et al. Curr Opin Immunol. 2002 Oct;14(5):666-72. doi: 10.1016/s0952-7915(02)00384-9. Curr Opin Immunol. 2002. PMID: 12183170 Review.

3

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection.

Harandi AM, Eriksson K, Holmgren J. Harandi AM, et al. Among authors: eriksson k. J Virol. 2003 Jan;77(2):953-62. doi: 10.1128/jvi.77.2.953-962.2003. J Virol. 2003. PMID: 12502811 Free PMC article.

4

Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.

Eriksson K, Fredriksson M, Nordström I, Holmgren J. Eriksson K, et al. Infect Immun. 2003 Apr;71(4):1740-7. doi: 10.1128/IAI.71.4.1740-1747.2003. Infect Immun. 2003. PMID: 12654787 Free PMC article.

5

Recent developments in mucosal immunomodulatory adjuvants.

Harandi AM, Sanchez J, Eriksson K, Holmgren J. Harandi AM, et al. Among authors: eriksson k. Curr Opin Investig Drugs. 2003 Feb;4(2):156-61. Curr Opin Investig Drugs. 2003. PMID: 12669375 Review.

6

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges.

Holmgren J, Czerkinsky C, Eriksson K, Mharandi A. Holmgren J, et al. Among authors: eriksson k. Vaccine. 2003 Jun 1;21 Suppl 2:S89-95. doi: 10.1016/s0264-410x(03)00206-8. Vaccine. 2003. PMID: 12763689 Review.

7

Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I-restricted cytotoxic T cells and the rejection of a cognate antigen-expressing model tumor.

Eriksson K, Sun JB, Nordström I, Fredriksson M, Lindblad M, Li BL, Holmgren J. Eriksson K, et al. Eur J Immunol. 2004 May;34(5):1272-81. doi: 10.1002/eji.200324368. Eur J Immunol. 2004. PMID: 15114660 Free article.

8

Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Eriksson K, Nordström I, Czerkinsky C, Holmgren J. Eriksson K, et al. Clin Exp Immunol. 2000 Aug;121(2):283-8. doi: 10.1046/j.1365-2249.2000.01282.x. Clin Exp Immunol. 2000. PMID: 10931143 Free PMC article.

9

Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.

Sun JB, Eriksson K, Li BL, Lindblad M, Azem J, Holmgren J. Sun JB, et al. Among authors: eriksson k. Clin Immunol. 2004 Jul;112(1):35-44. doi: 10.1016/j.clim.2004.03.001. Clin Immunol. 2004. PMID: 15207780

10

Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.

Svensson A, Nordström I, Sun JB, Eriksson K. Svensson A, et al. Among authors: eriksson k. J Immunol. 2005 May 15;174(10):6266-73. doi: 10.4049/jimmunol.174.10.6266. J Immunol. 2005. PMID: 15879125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

889 results

Search Page